ClinConnect ClinConnect Logo
Search / Trial NCT04054440

Outpatient Office Based Endovascular Procedures

Launched by METHODIST HEALTH SYSTEM · Aug 12, 2019

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Office Based Angiosuite

ClinConnect Summary

Endovascular surgery combined with the demands of patients and physicians for less invasive procedures, have make this type of surgery one of the most innovative fields in medicine. However the endovascular experience in an office-based angiosuite is different from that in a hospital suite, and has been viewed in the past by some physicians as unsafe because it lacks the safety net of immediate hospital resources. In 2005, medicine allowed endovascular procedures to be performed in the office setting. The results of this study will serve as a starting point for future trials concentrating o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years.
  • Diagnosis of peripheral arterial disease (PAD), chronic venous insufficiency, dialysis access and malfunctioning arteriovenous fistulas, varicose veins, vertebrobasilar insufficiency, and thoracic outlet syndrome.
  • Procedures performed as an outpatient in an office based angiosuite.
  • Exclusion Criteria:
  • Age ≤ 18 years

About Methodist Health System

Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Trial Officials

Sam S Ahn, MD

Principal Investigator

DFW Vascuclar

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials